Prestige Consumer Healthcare Inc. · NYSE:PBH

Prestige Consumer Healthcare — Prestige Brands Holdings — Q4 FY2011 Earnings Presentation

26 slides from Prestige Consumer Healthcare's earnings presentation, May 12, 2011

  1. Slide 1: Review of Fourth Quarter & FY'11 Results

    ae Er PrestigeBrands ye Review of Fourth Quarter & F’11 Results Matt Mannelly, President & CEO Ron Lombardi, CFO May 12, 2011

  2. Slide 2: Safe Harbor

    Safe Harbor Di During this call statements may be made by management of their beliefs and expectations as to the Company's future operating results. Statements of management's expectations of what might occur with respect to future operating results are what is known as forward- looking statements.

  3. Slide 3: Fourth Quarter Highlights

    Fourth Quarter Highlights = Strong financial performance for the quarter - Net Revenue growth of 4.1%, excluding the impact of acquisitions - Adjusted EPS of $0.18, up 28.6% versus prior year - Cash Flow from Operating Activities of $25.0 million, up from $8.9 million prior year = New strategic focu

  4. Slide 4: Strong Topline Growth

    Strong Topline Growth Q4 Net Revenue (% Growth) @@FY2010 G@BFY2011 37.8% [> $96.4 rLaee > $69.9 $69.9 $72.8 plese [> $33.1 _ $39.9 Prestige Total Excluding Acquisitions Core OTC Excluding Acquisitions clear CVE aie mets eBrands Dollar values in milion

  5. Slide 5: More Effective and Increased Investment in A&P

    More Effective and Increased Investment in A&P... Select Q4 Initiatives PediaCare@® national TV, Digital, and social campaign PediaCare and Little Remedies® pediatrician support 20% increase in Chloraseptio® TV advertising 50%+ increase in Clear Eyes® to support new item introductions Little Fevers®

  6. Slide 6: Driving Accelerated Consumption Growth

    ..Driving Accelerated Consumption Growth 34 Consecutive Quarter of Growth in FY2011 Quarterly A&P Spending (% of Net Revenue) HEEIFY2010: $20.9 million (10.5%) HEBFY2011: $42.9 million (12.7%) $13.1 ales 20.6% 14.2% a a — (6.4%) Qi Q2 Q3 a4 eBrands Source: IRI FDMH dollar sales

  7. Slide 7: Core OTC Brands Continued to Significantly Outperform Their Categories in Q4

    Core OTC Brands Continued to Significantly Outperform Their Respective Categories In Q4 — — M@ibrand Core OTC Hiicategory PBH Core: 21.4% Acquired: 53.2% Category: 8.6% Category: 9.7% ia a Se Rewer 361.6% 29% ww \ “es 32.8% = 27.6% & ; 12.8% ae Ae vod 14.2% 12.39 13.9% 112.3% 10.7% 3% 3.29 ay = (8.6

  8. Slide 8: Household Consumption Trends Consistent With Category Trends

    Household Consumption Trends Consistent With Category Trends Consumption Trends I es to Stabilize Comet Mierand . Micategory Q3 a Q4 93 Q4 |_| lines | | (4.4%) 4.3%) (2.9%J 5%) (4.6%) C- (6.5%) (12.0%) . Abrasive r Non-Abrasive 7 Cleaners Cleaners Strengthen consumer value proposition ~ Introduced C

  9. Slide 9: FY2011: A Transformational Year For Prestige

    FY2011: A Transformational Year For Prestige _———— PrestigeBrands

  10. Slide 10: I. Grow Five Core OTC Brands

    I. Grow Five Core OTC Brands Five Core OTC Brands FY2011 \ +9.3% ) Factory Shipments Little . a ‘ +11.7% Remedies’? © y Consumption E Doctoi stigeBrands 10

  11. Slide 11: II. Build Brands through Increased, Innovative and Effective A&P Support

    II. Build Brands through Increased, Innovative and Effective A&P Support FY2011 Shipment and Consumption Growth mBrand mCategory Fy2011 NetRevenue my <m <r ame NMF 0 ONMF 0 ONME | NME ly Growth 167.5% 34.5% en 13.7% 13.3% E530 8.6% 7.0% ° 5 0.2% - 5.5% | % 1.2% | % 6.4% Oo = 1.9% (3.5%) (3.6%) Oo (3

  12. Slide 12: III. Two Transformational OTC Acquisitions for Prestige

    III. Two Transformational OTC Acquisitions for Prestige \CKSMITH selena November 2010. January 2011 Dramamine Dramamine’ Tey stacicenarn BRANDS #1 brand with strong competitive position Strategic core OTC franchise Ability to deliver growth Attractive margin profile = Adds 3 scale OTC brands in attr

  13. Slide 13: III. Acquisitions Have Transformed the Portfolio into a Largely OTC Focus

    III. Acquisitions Have Transformed the Portfolio into a Largely OTC Focus PrestigeBrands (Q3 20 BuaccsmrH + Dramamane’ BRANDS ig Personal Household Household 5 Core OTC Brands 9 Core OTC Brands “a 2 «Oa : « Little Remedies Clear "32 *(uotXs §= DEES Little Remedies Clear eyes eyes z Dramamine (eae Br

  14. Slide 14: III. Recently Acquired Brands Contribute Meaningfully to Consumption Gains

    III. Recently Acquired Brands Contribute Meaningfully to Consumption Gains PrestigeBrands Acquired Brands PréstigeBrands Mierand Hicategory Core OTC Acquired: 24.5% Clear por SVES rinse remedies [2 Category: 2. Category: (2.1%) 4p recoelras ie *Gowss LEED) "2? Dramamine eae 167.5% Atle Remedies 34.5

  15. Slide 15: IV. Strengthen Management Team and Organizational Capabilities

    IV. Strengthen Management Team and Organizational Capabilities = New leadership team in key functional areas - Sales/Marketing - Finance j ; = Operations Dpera ; Marketing People = Integration of Sales and Marketing activities for improved consumer and Process customer results = Implement new 3-year

  16. Slide 16: V. Deliver Strong Cash Flow and Financial Performance

    V. Deliver Strong Cash Flow and Financial Performance FY2011 ancial Highlights (% Growth) @@FY2010 M@BFY2011 [ 15.0% [> $3385 $2928 rlassoe]> rlsz.9%]> = le 101.3 sua * én $057 | 7 a Net Revenue ‘Adjusted EBITDA Adjusted EPS Cash Flow From Operating Activities eBrands Dollar values in millions Note:

  17. Slide 17: Introduction to Financial Results

    Introduction to Financial Results = Strong A&P investment behind core OTC brands and Blacksmith Brands acquisition driving revenue growth trends = Net Income and EPS growth over FY2010 Q4 = Solid Q4 performance includes investments for growth 2 PrestigeBrands 17

  18. Slide 18: Consolidated Financial Summary

    Consolidated Financial Summary Net Revenue Gross Profit % Margin Aap % Net Revenue Ges % Net Revenue Adjusted EBITDA % Margin Ded % Net Revenue Operating Income % Margin Adjusted Net Income Adjusted Earnings Per Share Earnings Per Share - As Reported Dollar yslues in millions Note! Eneludes adjustme

  19. Slide 19: Consolidated Financial Summary (Full Year)

    Consolidated Financial Summary Fy2010 $ 292.6 Net Revenue Gross Profit % Margin ARP % Margin Gea % Margin Adjusted EBITDA % Margin Dea % Margin Operating Income % Margin Adjusted Net Income Adjusted Earnings Per Share Earnings Per Share - 4s Reported Dollar yslues in millions Note! Eneludes adjustme

  20. Slide 20: Net Income and EPS Reconciliation

    Net Income and EPS Reconciliation oa FullYear Wat nome EPS Wat nome EPS G4FY2011 Adjustedfor Onetimeltems § 88 § O18 $ 399 § O78 Onetime Adjustment Inorementa Interest Expense to Finance Dramamine 2) (002) Inventory Step-up Associated with Purchar® Price Allocation: Blackemith oon (008) en (0.13) Dr

  21. Slide 21: Q4 Segment Financial Summary

    Q4 Segment Financial Summary FY2011 94 LE comments Net Revenue Fy2011 Fy2010 % Change Gross Profit Fy2o11 % Margin Fy2oio % Margin ARP Fy2011 Fy2010 % Change Fy2011 Fy2010 % Change Dollar yslues in millions Note! Eneludes adjustments detailed on page 20 $ 71.6 42.9 66.5% 42.0 58.8% 26.3 61.2% 12.8 4

  22. Slide 22: Full Year Segment Financial Summary

    Full Year Segment Financial Summary OTC Household Gonsoli = OTC segment revenue grew 29.0% Net Revenue with core OTC up 9% (excluding Fy2011 $2346 § 1019 $§ 338.8 acquisitions) as acquisitions added Fy2010 181.9 110.7 292.6 $38.8 million sa-change 2G, iB). 4906 = Household revenue declined 7.9% due

  23. Slide 23: Prestige Strength: Strong Cash Flow from Operations

    Prestige Strength: Strong Cash Flow from Operations Net Income Depreciation and Amortization Other Non-Cash Operating Items Working Capital Cash Flow from Operations Dollat values in millions = Q4 cash flow excluding the impact of O4'11 FY2011 acquisitions totaled approximately $ 6.4 $29.2 $15 milli

  24. Slide 24: Positioned Entering FY2012

    ioned Entering FY2012 = Significantly improved financial profile in FY2011 = Clear goals for FY2012 to build on success and momentum: - Drive Core OTC growth through proven increased and innovative A&P investment over FY2011 levels - Develop long term potential of Blacksmith and Dramamine brands fol

  25. Slide 25: Clear Roadmap for Value Creation

    Clear Roadmap for Value Creation _— PrestigeBrands _—— PrestigeBrands 25

  26. Slide 26: a em

    a em PrestigeBrands _—— PrestigeBrands 26

Prestige Brands Holdings — Q4 FY2011 Earnings Presentation on 6ix